Sentisearch, Inc. (SSRC) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Sentisearch, Inc. (SSRC) opera en el sector Industrials, cotizado por última vez a $ con una capitalización de mercado de 0. La acción obtiene una puntuación de 57/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 16 mar 2026Perfil de Operaciones Industriales de Sentisearch, Inc. (SSRC)
SentiSearch, Inc., founded in 2000, operates as a development stage company within the specialty business services sector, focusing on insect chemosensation and olfaction. The company holds licenses and patent applications related to insect receptor genes, with the goal of developing and commercializing products and services in this niche area.
Tesis de Inversión
SentiSearch, Inc. presents a high-risk, high-reward investment opportunity due to its early development stage and focus on a niche market. The company's value hinges on its ability to successfully develop and commercialize products and services based on its licensed technologies and patent applications in insect chemosensation and olfaction. With a negative P/E ratio of -0.01 and a profit margin of -549.7%, the company's financial performance is currently unsustainable. Key catalysts include successful research outcomes and strategic partnerships. The high beta of 9.98 indicates significant volatility. Investors should carefully consider the risks associated with development stage companies and the uncertainty surrounding the commercial viability of SentiSearch's technologies.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $0.00B, reflecting its status as a micro-cap or nano-cap company.
- Negative P/E ratio of -0.01, indicating the company is not currently profitable.
- Profit margin of -549.7%, highlighting significant losses relative to revenue.
- Gross margin of 100.0%, suggesting high potential profitability if the company can generate substantial revenue.
- Beta of 9.98, indicating very high volatility compared to the overall market.
Competidores y Pares
Fortalezas
- Exclusive license in a niche technology area.
- Patent applications for insect receptor genes.
- Potential for innovative pest control solutions.
- High gross margin potential (100%).
Debilidades
- Development stage company with no current revenue.
- Significant losses and negative profit margin (-549.7%).
- High beta indicating high volatility.
- Small company size with only 1 employee.
Catalizadores
- Upcoming: Successful results from ongoing research and development efforts.
- Upcoming: Securing strategic partnerships with research institutions or industry players.
- Upcoming: Obtaining regulatory approvals for new pest control products.
- Ongoing: Licensing of intellectual property to generate revenue.
Riesgos
- Potential: Failure to successfully develop and commercialize its technologies.
- Potential: Competition from larger, more established companies.
- Potential: Regulatory hurdles for new pest control products.
- Ongoing: Dependence on securing additional funding.
- Ongoing: Limited liquidity due to OTC Other tier status.
Oportunidades de crecimiento
- Development of Novel Pest Control Solutions: SentiSearch can leverage its expertise in insect chemosensation to develop innovative pest control products. The global pest control market is estimated to reach $30 billion by 2028, offering a substantial opportunity for companies with effective and environmentally friendly solutions. Timeline: 3-5 years for product development and regulatory approvals.
- Applications in Agriculture: Insect chemosensation plays a crucial role in plant-insect interactions. SentiSearch can develop technologies to enhance crop protection and improve agricultural yields. The precision agriculture market is projected to reach $12.9 billion by 2027, providing a potential market for SentiSearch's technologies. Timeline: 2-4 years for research and development.
- Environmental Monitoring: Insect chemosensors can be used to detect pollutants and monitor environmental conditions. SentiSearch can develop sensor-based solutions for environmental monitoring applications. The environmental monitoring market is expected to reach $27.9 billion by 2028, creating opportunities for specialized sensor technologies. Timeline: 3-5 years for sensor development and deployment.
- Partnerships with Research Institutions: Collaborating with universities and research institutions can accelerate the development and validation of SentiSearch's technologies. These partnerships can provide access to funding, expertise, and infrastructure. Timeline: Ongoing, with continuous collaboration efforts.
- Licensing of Intellectual Property: SentiSearch can generate revenue by licensing its patents and technologies to other companies in related industries. This can provide a low-risk revenue stream and expand the reach of its technologies. Timeline: Ongoing, with continuous licensing efforts.
Oportunidades
- Growing market for pest control solutions.
- Potential applications in agriculture and environmental monitoring.
- Partnerships with research institutions.
- Licensing of intellectual property.
Amenazas
- Competition from larger, more established companies.
- Regulatory hurdles for new pest control products.
- Uncertainty surrounding the commercial viability of its technologies.
- Dependence on securing additional funding.
Ventajas competitivas
- Patents and patent applications related to insect receptor genes.
- Exclusive license to develop products and services in its niche area.
- Specialized expertise in insect chemosensation and olfaction.
Acerca de SSRC
Founded in 2000, SentiSearch, Inc. is a development stage company operating within the specialty business services sector. The company's core focus lies in the realm of insect chemosensation and olfaction, leveraging licensed technologies and patent applications to develop products and services. SentiSearch holds a license enabling it to develop, manufacture, import, sell, and distribute products related to insect chemosensation and olfaction. The company's intellectual property portfolio includes patent applications pertaining to nucleic acids and proteins of insect or odorant receptor genes. Currently based in New York, the company's activities are centered around research and development, with the long-term objective of commercializing its technologies. As a development stage company, SentiSearch is pre-revenue and focused on advancing its research and development efforts.
Qué hacen
- Holds a license to develop products and services in insect chemosensation and olfaction.
- Aims to manufacture products related to insect chemosensation and olfaction.
- Intends to import products and services in the specified areas.
- Plans to use its technology to create new products and services.
- Seeks to sell and distribute its products in the market.
- May rent or lease its products to customers.
Modelo de Negocio
- Developing and commercializing products based on insect chemosensation and olfaction technologies.
- Licensing its intellectual property to other companies.
- Generating revenue through sales, distribution, and rental/leasing of its products.
Contexto de la Industria
SentiSearch, Inc. operates within the specialty business services sector, focusing on the niche area of insect chemosensation and olfaction. This sector involves companies providing specialized services to various industries, often requiring unique expertise and intellectual property. The market for insect chemosensation technologies is relatively small but has potential applications in areas such as pest control, agriculture, and environmental monitoring. SentiSearch faces competition from companies with broader expertise in biotechnology and chemical sensing, including BBRW (BrewBilt Manufacturing Inc.), IMHCW (Immunocore Holdings plc Warrants), LEAS (Lease Corporation of America), PSGI (Premier Security Group, Inc.), and RNWR (RenovoRx, Inc.).
Clientes Clave
- Potential customers in the pest control industry.
- Agricultural companies seeking crop protection solutions.
- Environmental monitoring agencies and organizations.
Finanzas
Gráfico e información
Precio de la acción de Sentisearch, Inc. (SSRC): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para SSRC.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para SSRC.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para SSRC.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de SSRC en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Clasificación
Industria Specialty Business ServicesLiderazgo: Joseph K. Pagano
CEO
Joseph K. Pagano is the CEO of SentiSearch, Inc. His background and experience prior to joining SentiSearch are not detailed in the provided information. As the head of a development stage company, his role involves overseeing the company's research and development efforts, securing funding, and establishing strategic partnerships.
Historial: Due to the limited information available, it is difficult to assess Joseph K. Pagano's track record at SentiSearch. The company is still in the development stage, and there are no significant milestones or achievements to report at this time.
Información del mercado OTC de SSRC
The OTC Other tier represents the lowest tier of the OTC market, indicating that SentiSearch, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it difficult for investors to assess their financial health and operations. This tier is often associated with higher risk and greater potential for fraud compared to companies listed on major exchanges like the NYSE or NASDAQ.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure due to OTC Other tier status.
- Low liquidity and wide bid-ask spreads.
- Potential for price manipulation and fraud.
- Higher risk of delisting or going out of business.
- Limited regulatory oversight compared to major exchanges.
- Verify the company's registration and legal status.
- Review any available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues.
- Patent applications related to insect receptor genes.
- Exclusive license to develop products in its niche area.
- Company has been in existence since 2000.
- Presence of a CEO (Joseph K. Pagano).
Lo Que los Inversores Preguntan Sobre Sentisearch, Inc. (SSRC)
¿Cuáles son los factores clave para evaluar SSRC?
Sentisearch, Inc. (SSRC) actualmente tiene una puntuación IA de 57/100, indicando puntuación moderada. Fortaleza clave: Exclusive license in a niche technology area.. Riesgo principal a monitorear: Potential: Failure to successfully develop and commercialize its technologies.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de SSRC?
SSRC actualmente puntúa 57/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de SSRC?
Los precios de SSRC se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre SSRC?
La cobertura de analistas para SSRC incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en SSRC?
Las categorías de riesgo para SSRC incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Failure to successfully develop and commercialize its technologies.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de SSRC?
La relación P/E para SSRC compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está SSRC sobrevalorada o infravalorada?
Determinar si Sentisearch, Inc. (SSRC) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de SSRC?
Sentisearch, Inc. (SSRC) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited information available on SentiSearch, Inc.
- OTC market investments are inherently risky.
- Financial data may not be up-to-date.